| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 45M75JVK38 |
Pharmacology
| Primary Target | |
|---|---|
| proprotein convertase subtilisin/kexin type 9 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cardiovascular Diseases | 3 | D002318 | ClinicalTrials |
| Hyperlipidemias | 3 | D006949 | ClinicalTrials |
| Hyperlipoproteinemia Type II | 3 | D006938 | ClinicalTrials |
| Hypercholesterolemia | 2 | D006937 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1407495-02-6 |
| ChEMBL | CHEMBL3137349 |
| FDA SRS | 45M75JVK38 |
| Guide to Pharmacology | 7730 |
CONTENTS